Davenport Downgrades Orexigen Therapeutics (OREX) to Neutral

July 16, 2010 9:36 AM EDT
Get Alerts OREX Hot Sheet
Price: $0.43 -6.52%

Rating Summary:
    3 Buy, 10 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 41 | New: 17
Trade OREX Now!
Join SI Premium – FREE
Davenport downgrades Orexigen Therapeutics (Nasdaq: OREX) from Buy to Neutral.

To see all the upgrades/downgrades on shares of OREX, visit our Analyst Ratings page.

Orexigen Therapeutics, Inc. (Orexigen) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity.

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Davenport

Add Your Comment